Catalyst has in-person and virtual activities.

During the six-month program, participating Fellows and Faculty will be dispersed nationally. Some of the Fellows and Faculty will be from the local VA and some from outside the VA. Throughout the Catalyst process, Fellows will work in small teams, supported by Faculty and external advisors with diverse backgrounds. Team meetings, workshops and presentations will be held virtually (via Zoom), which has worked well for Catalyst programs since March 2020.  Virtual meetings allow for cross-site collaboration on projects.

We are also planning what we call intensifications. These are three 3-day working sessions, planned as in-person events and may require travel to MIT. 

Live information sessions

Tuesday, May 28, at 1pm ET Register here
Wednesday, July 10, at 6pm ET Register here

Application and enrollment timetable:
August 5: Cycle 1 Application Close
September 6: Interviews will be held virtually, 10am-4pm ET
October 14: Deadline to respond to admissions for program admittance

Cycle 2
Complete, submitted applications will be considered on a rolling basis. As we have a limited number of slots available for the cohort, candidates are encouraged to complete the app as soon as possible and to be in touch with the program office (catalyst-program@mit.edu).

Fellows are participants in the program who are learning the Catalyst process and doing the work of identifying unmet medical needs, devising and validating solution ideas, planning, and executing research. Fellows profiles typically include PhD students, postdocs, researchers in a company or academia, or clinicians (residents, fellows, attendings) who would like to accelerate the impact of biomedical research. They typically have experience or interest in any domain area linked to health technology: life sciences, engineering, biomedical engineering, data science or any clinical domain. Fellows form what we call an “innovation cohort” and they organically form teams throughout the program.

Generally, we aim to have a cohort of 10-16 Fellows.

Catalyst hopes to have a near equal mix of VA- and non-VA affiliated Fellows. Once accepted into the program, all Fellows participate equally, and we strive to ensure that the experience is consistent among participants.

We welcome applications from individuals at any career stage, including advanced pre-doctoral, post-docs, clinicians, entrepreneurs, and professionals. Typically, Catalyst Fellows are comparatively early in their career, but if you are wondering, just ask.

This program is not designed to help you progress on an existing project or idea, but to help you leverage your knowledge and experience to initiate new research projects with high translational potential in collaboration with a strong network of partners. The program is designed to guide teams in a process to discover and validate meaningful unmet clinical needs and plan an executable research project proposal, while surrounding you (and developing relationships) with all the stakeholders that may increase the probability of impact for the cohort’s project portfolio.

The cohort of Catalyst Fellows will, as a group, investigate medical needs and consider which to pursue; at which point various solutions will be considered. In general multiple fellows will pursue each idea, and each fellow will be involved in investigating several needs. At the conclusion of Catalyst Phase 1, the group of Catalyst Fellows will have developed a portfolio of validated project opportunities. The projects will not necessarily be in an area that you have been working in until this point, though is it highly likely there will be elements of the project that overlap your interests and expertise.

Documents and information you will need to submit in the Application Form include:

1. Curriculum Vitae (required)
2. Reference letters (2 required)
3. Reference contacts (required)
4. Application questions (previewed below)

Application questions

The objective of these questions is to know more about you and your experiences. Remember that Catalyst will guide and train you to identify and validate unmet needs, define solutions, and design new research projects with high translational potential during the program. You are not applying with an existing project to the Catalyst program; you are applying as a talented and passionate individual with valuable skills to make an impact in healthcare.

Please list your core competencies, including domains of expertise and experience. (75 word max]

Help us understand your CV in context. Tell us about one or two of your non-classroom, professional or research experiences—describe your role in understanding challenges, applying learnings, and influencing outcomes. [150 word max]

Please tell us why you are interested in being a Fellow in the Catalyst Program. [75 word max]

What else should we know about you? (Optional)

Fellows are expected to attend the following activities:

• Sessions: Weekly working sessions will run on Wednesdays from 10am ET to 1pm ET from January 6th to July 2nd, 2025. Weekly sessions will be offered virtually. Additionally, weekly discussion groups will meet online Mondays from 10:00am to 11:00am ET. (Sessions may not run in this format during the three intensifications described below.)
• Intensifications: Fellows are required to participate in the following 3-day working sessions, which may be virtual or involve travel to MIT:
  • Intensification I, January 21–23, 2025 — Theme: Need generation/validation
  • Intensification II,  February 25–27, 2025  — Theme: Solution Generation
  • Intensification III, May 6–8, 2025  — Theme: Plan Generation

Fellows are expected to dedicate an average of 10-15 hours/week or 20% time to the regular weekly activities of the program, including Sessions, personal work and teamwork – personal and team work in a flexible schedule format.

For the Intensifications, Fellows are expected to work full time.

There will be one weekly 3-hour session where the group will get together with Faculty to discuss the ideas together, and one 1-hour weekly discussion meeting. Everyone is expected to attend those meetings. The time for the working meetings is Wednesdays, 10am-1pm ET, and the discussion meetings will be Mondays 10am-11am. The Intensifications are required, 3-day, full-time events plus travel to MIT, January 21–23, February 25–27, May 6–8). The remaining time is flexible, depending on the group and project requirements. You will need to be proactive in discussing with your supervisor how to best protect time for group and project work.

If you have a full-time job (or you are currently committed to a full-time activity) and you are willing to reduce your current activity dedication (temporarily, during the program) to participate in Catalyst, you will need your current supervisor’s approval and support, if accepted, before committing to the program. The VA will have a procedure for this, which will be shared when acceptances are sent out.

You can provide your supervisor with information about the program, and explain the commitment required and the value of your participation in Catalyst for your current organization. We can also help you with talking points for that if needed.

While many programs of this nature require participants to pay tuition, Catalyst is offered tuition-free, thanks to the generosity of our donors and partners.

Non-VA Fellows should plan to pay for their own expenses but may request support for non-local travel if it presents a hardship. The VA will support travel through their systems. More details will be provided to accepted Fellows.

In Phase 1, you will learn the Catalyst methodology for biomedical research innovation. Faculty mentors will support in teams in identifying and validating unmet needs in healthcare, especially around the innovation priority areas. During the program, teams will develop a deep understanding of the problem and ideate solutions. You will then develop a research project plan further validate and de-risk your project concept. The research project plans form the basis of the “final” presentations and these projects form the cohort’s portfolio.

After the first 6 months of the program, Fellows transition to Phase 2. Some projects transition in weeks, others in months. During the transition, Faculty and teams form working groups that meet regularly to assess the projects’ progress and determine next steps. Phase 2 is concerned with executing the research plan—doing the work to implement the solution.

In Phase 2, follow-on funding will be pursued for those projects that are found to be viable and promising. In particular, our partners are committed to seriously considering funding of projects that emerge from Catalyst Phase 1.

Opportunities to continue working on the project with 20% effort or higher will be determined on an individual basis. This is also the point at which additional individuals (PIs, students, etc.) are recruited to execute the project.

No, you will critically examine and document how the projects, if successful, will have impact (societal, economic, etc) in the “real world.”  While in some cases that impact will arise through entrepreneurial ventures, others may have impact in other ways, such as advances in knowledge, policy developments, new clinical paradigms, or new research initiatives. We do not anticipate new IP generation during Phase 1, when the Fellows develop a portfolio of validated project opportunities. Projects that proceed to Phase 2 when the solution ideas are reduced to practice, there is often new IP generated. This IP is managed by existing institutional structures and there is considerable precedent for managing IP when inventors come from multiple institutions. 

Catalyst is organized in a way that is not likely to generate Intellectual Property during the program. IP considerations would arise during the execution of the research projects (if Fellows execute them).  MIT and the VA have resources available to Fellows for more information as it becomes relevant.